Multiple sclerosis prevalence in the United States commercially insured po- pulation. Neurology 86, 1014-1021.Dilokthornsakul P, Valuck RJ, Nair KV, Corboy JR, Allen RR, Campbell JD. Multiple sclerosis prevalence in the United States commercially insured population. Neurology. 2016;86:1014...
A. MULTIPLE SCLEROSIS MULTIPLE SCLEROSIS Definition • Autoimmune, chronic inflammatory, demyelinating disease of the central nervous system; intermittent episodic neurologic impairments of varying severity caused by multiple demyelinating lesions, often of different ages • Key pathologic features: •...
including Severe Acute Respiratory Syndrome-related Coronavirus-2 (SARS-CoV-2), the virus responsible for the Coronavirus disease-19 (Covid-19) pandemia, and Multiple Sclerosis (MS), and whether an increase of the prevalence of MS after the current Covid-19 pandemia should be expected, examinin...
Multiple sclerosis (MS) is the most common demyelinating disorder of the CNS. The peak incidence is at 30 years of age. MS rarely commences in childhood or over the age of 50 years. Females are affected twice as frequently as males. MS shows a characteristic geographical distribution. It is...
Neurodegeneration in multiple sclerosis: novel treatment strategies. Expert Rev Neurother. 2012;12(9):1061–1076. 2. Dilokthornsakul P, Valuck RJ, Nair KV, Corboy JR, Allen RR, Campbell JD. Multiple sclerosis prevalence in the United States commercially insured population. Neurology. 2016;86(11...
The demand for Multiple Sclerosis (MS) drugs in Europe has been on the rise in recent years, driven by various factors such as increasing prevalence of MS, rising healthcare expenditure, and advancements in drug development technologies.
Background: Multiple sclerosis (MS) is the most common chronic neurologic disease of young adults, placing a heavy burden on patients, families, and the healthcare system. Ongoing surveillance of the incidence and prevalence of MS is critical for health policy and research, but feasible options ...
Trends in the market: The Multiple Sclerosis Drugs market in Singapore is expected to grow due to the increasing prevalence of MS in the country. The market is also being driven by the introduction of new drugs that are more effective and have fewer side effects. The demand for these drugs...
Epidemiology of multiple sclerosis: a critical overview. The decisive conclusions to be drawn from the available epidemiological data, mostly geography and prevalence, of MS are: (1) a north-south (as well as west-east in the United States) gradient exists independent of genetic/racial factors....
White individuals have the highest prevalence of multiple sclerosis (MS), according to a study published online May 15 inJAMA Neurology. Ad Michael Hittle, from the Stanford University School of Medicine in California, and colleagues calculated the U.S. prevalence of MS in Hispanic, non-Hispanic...